Enliven Therapeutics shares owned by Blackstone Group
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Blackstone Group
from 13F filings
Historical chart of Blackstone Group investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Blackstone Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $27M | 1.3M | 20.47 |
| 2025-06-30 | $27M | 1.3M | 20.06 |
| 2025-03-31 | $15M | 762k | 19.68 |
| 2024-12-31 | $8.4M | 373k | 22.50 |
| 2024-09-30 | $9.5M | 373k | 25.54 |
| 2024-06-30 | $7.5M | 321k | 23.37 |
| 2024-03-31 | $443k | 25k | 17.59 |